Oncimmune Holdings (UK) Buy Hold or Sell Recommendation
| ONC Stock | 1.14 0.05 4.20% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Oncimmune Holdings plc is 'Strong Sell'. Macroaxis provides Oncimmune Holdings buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ONC positions.
Check out Oncimmune Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Oncimmune and provide practical buy, sell, or hold advice based on investors' constraints. Oncimmune Holdings plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Oncimmune |
Execute Oncimmune Holdings Buy or Sell Advice
The Oncimmune recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Oncimmune Holdings plc. Macroaxis does not own or have any residual interests in Oncimmune Holdings plc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Oncimmune Holdings' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Oncimmune Holdings Trading Alerts and Improvement Suggestions
| Oncimmune Holdings generated a negative expected return over the last 90 days | |
| Oncimmune Holdings has high historical volatility and very poor performance | |
| Oncimmune Holdings may become a speculative penny stock | |
| Oncimmune Holdings has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 2.74 M. Net Loss for the year was (4.11 M) with profit before overhead, payroll, taxes, and interest of 1.23 M. | |
| Oncimmune Holdings generates negative cash flow from operations | |
| About 32.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Thyssenkrupp drops possible partial sale of marine division to Rheinmetall, Handelsblatt reports - Marketscreener.com |
Oncimmune Holdings Returns Distribution Density
The distribution of Oncimmune Holdings' historical returns is an attempt to chart the uncertainty of Oncimmune Holdings' future price movements. The chart of the probability distribution of Oncimmune Holdings daily returns describes the distribution of returns around its average expected value. We use Oncimmune Holdings plc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Oncimmune Holdings returns is essential to provide solid investment advice for Oncimmune Holdings.
| Mean Return | -3.29 | Value At Risk | -25.16 | Potential Upside | 9.68 | Standard Deviation | 10.37 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Oncimmune Holdings historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Oncimmune Holdings Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 31K | (270K) | 158K | (3K) | (3.5K) | (3.6K) | |
| Change In Cash | 4.4M | (6.1M) | 1.8M | (2.4M) | (2.1M) | (2.0M) | |
| Free Cash Flow | (5.6M) | (6.7M) | (6.8M) | (3.4M) | (3.1M) | (3.2M) | |
| Depreciation | 740K | 1.4M | 981K | 263K | 302.5K | 437.6K | |
| Other Non Cash Items | 727K | 943K | (416K) | 72K | 64.8K | 61.6K | |
| Capital Expenditures | 1.1M | 504K | 31K | 9K | 10.4K | 9.8K | |
| Net Income | (5.7M) | (9.5M) | (6.2M) | (4.1M) | (3.7M) | (3.9M) | |
| End Period Cash Flow | 8.6M | 2.5M | 3.2M | 846K | 761.4K | 723.3K | |
| Change To Netincome | 353K | (835K) | 326K | 2.3M | 2.7M | 2.8M | |
| Investments | (856K) | (504K) | 11.6M | 1.2M | 1.3M | 1.3M |
Oncimmune Holdings Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Oncimmune Holdings or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Oncimmune Holdings' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Oncimmune stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -3.47 | |
β | Beta against Dow Jones | -1.62 | |
σ | Overall volatility | 10.59 | |
Ir | Information ratio | -0.31 |
Oncimmune Holdings Volatility Alert
Oncimmune Holdings plc is displaying above-average volatility over the selected time horizon. Oncimmune Holdings plc is a potential penny stock. Although Oncimmune Holdings may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Oncimmune Holdings plc. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Oncimmune instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Oncimmune Holdings Fundamentals Vs Peers
Comparing Oncimmune Holdings' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Oncimmune Holdings' direct or indirect competition across all of the common fundamentals between Oncimmune Holdings and the related equities. This way, we can detect undervalued stocks with similar characteristics as Oncimmune Holdings or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Oncimmune Holdings' fundamental indicators could also be used in its relative valuation, which is a method of valuing Oncimmune Holdings by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Oncimmune Holdings to competition |
| Fundamentals | Oncimmune Holdings | Peer Average |
| Return On Equity | -7.61 | -0.31 |
| Return On Asset | -0.3 | -0.14 |
| Profit Margin | (1.32) % | (1.27) % |
| Operating Margin | (1.18) % | (5.51) % |
| Current Valuation | 5.55 M | 16.62 B |
| Shares Outstanding | 111.77 M | 571.82 M |
| Shares Owned By Insiders | 31.54 % | 10.09 % |
| Shares Owned By Institutions | 35.20 % | 39.21 % |
| Price To Book | 49.27 X | 9.51 X |
| Price To Sales | 0.49 X | 11.42 X |
| Revenue | 2.74 M | 9.43 B |
| Gross Profit | 1.23 M | 27.38 B |
| EBITDA | (3 M) | 3.9 B |
| Net Income | (4.11 M) | 570.98 M |
| Total Debt | 5.12 M | 5.32 B |
| Book Value Per Share | (0.03) X | 1.93 K |
| Cash Flow From Operations | (3.38 M) | 971.22 M |
| Earnings Per Share | (0.05) X | 3.12 X |
| Target Price | 50.0 | |
| Number Of Employees | 40 | 18.84 K |
| Beta | 1.73 | -0.15 |
| Market Capitalization | 1.33 M | 19.03 B |
| Total Asset | 4.9 M | 29.47 B |
| Retained Earnings | (46.78 M) | 9.33 B |
| Working Capital | (818 K) | 1.48 B |
| Net Asset | 4.9 M |
Oncimmune Holdings Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Oncimmune . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Oncimmune Holdings Buy or Sell Advice
When is the right time to buy or sell Oncimmune Holdings plc? Buying financial instruments such as Oncimmune Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Oncimmune Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investing Thematic Idea Now
Investing
Companies involved in money management and investment banking services. The Investing theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Oncimmune Stock
Oncimmune Holdings financial ratios help investors to determine whether Oncimmune Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncimmune with respect to the benefits of owning Oncimmune Holdings security.